{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T19:40:31Z","timestamp":1772998831602,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":190,"publisher":"Springer New York","isbn-type":[{"value":"9781461406495","type":"print"},{"value":"9781461406501","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-1-4614-0650-1_8","type":"book-chapter","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T06:43:17Z","timestamp":1315636997000},"page":"121-138","source":"Crossref","is-referenced-by-count":37,"title":["Glycosphingolipids and Kidney Disease"],"prefix":"10.1007","author":[{"given":"Andrew R.","family":"Mather","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah J.","family":"Siskind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"2","key":"8_CR1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","volume":"9","author":"YA Hannun","year":"2008","unstructured":"Hannun YA, Obeid LM. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 2008; 9(2): 139\u2013150.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"38","key":"8_CR2","doi-asserted-by":"crossref","first-page":"11247","DOI":"10.1021\/bi061307z","volume":"45","author":"CJ Clarke","year":"2006","unstructured":"Clarke CJ, Snook CF, Tani M et al. The extended family of neutral sphingomyelinases. Biochemistry 2006; 45(38):11247\u201311256.","journal-title":"Biochemistry"},{"issue":"10","key":"8_CR3","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1096\/fj.08-108043","volume":"22","author":"EL Smith","year":"2008","unstructured":"Smith EL, Schuchman EH. The unexpectedrole of acid sphingomyelinase in cell death and the pathophysiology of common diseases. FASEB J 2008; 22(10):3419\u20133431.","journal-title":"FASEB J"},{"issue":"5","key":"8_CR4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1043-6618(03)00054-9","volume":"47","author":"DS Menaldino","year":"2003","unstructured":"Menaldino DS, Bushnev A, Sun A et al. Sphingoid bases and de novoceramide synthesis: enzymes involved, pharmacology and mechanisms of action. Pharmacol Res 2003; 47(5):373\u2013381.","journal-title":"Pharmacol Res"},{"issue":"2\u20133","key":"8_CR5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1388-1981(02)00335-9","volume":"1585","author":"DK Perry","year":"2002","unstructured":"Perry DK. Serine palmitoyltransferase: role in apoptotic de novo ceramide synthesis and other stress responses. Biochim Biophys Acta 2002; 1585(2\u20133):146\u2013152.","journal-title":"Biochim Biophys Acta"},{"issue":"16","key":"8_CR6","doi-asserted-by":"crossref","first-page":"11144","DOI":"10.1016\/S0021-9258(19)49887-6","volume":"267","author":"EC Mandon","year":"1992","unstructured":"Mandon EC, Ehses I, Rother J et al. Subcellular localization and membrane topology of serine palmitoyltransferase, 3-dehydrosphinganine reductase and sphinganine N-acyltransferase in mouse liver. J Biol Chem 1992; 267(16):11144\u201311148.","journal-title":"J Biol Chem"},{"issue":"9","key":"8_CR7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbalip.2008.06.002","volume":"1781","author":"C Mao","year":"2008","unstructured":"Mao C, Obeid LM. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine and sphingosine-1-phosphate. Biochim Biophys Acta 2008; 1781(9):424\u2013434.","journal-title":"Biochim Biophys Acta"},{"issue":"35","key":"8_CR8","doi-asserted-by":"crossref","first-page":"25001","DOI":"10.1074\/jbc.R600010200","volume":"281","author":"Y Pewzner-Jung","year":"2006","unstructured":"Pewzner-Jung Y, Ben-Dor S, Futerman AH. When do lasses (longevity assurance genes) become CerS (ceramide synthases)? Insights into the regulation of ceramide synthesis. J Biol Chem 2006; 281(35): 25001\u201325005.","journal-title":"J Biol Chem"},{"issue":"44","key":"8_CR9","doi-asserted-by":"crossref","first-page":"43452","DOI":"10.1074\/jbc.M307104200","volume":"278","author":"C Riebeling","year":"2003","unstructured":"Riebeling C, Allegood JC, Wang E et al. Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J Biol Chem 2003; 278(44):43452\u201343459.","journal-title":"J Biol Chem"},{"key":"8_CR10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1042\/BJ20050291","volume":"390","author":"Y Mizutani","year":"2005","unstructured":"Mizutani Y, Kihara A, Igarashi Y. Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem J 2005; 390(Pt 1):263\u2013271.","journal-title":"Biochem J"},{"key":"8_CR11","doi-asserted-by":"crossref","unstructured":"Schiffmann S, Ziebell S, Sandner J et al. Activation of ceramide synthase 6 by celecoxib leads to a selective induction of C16:0-ceramide. Biochem Pharmacol 80(11):1632\u20131640.","DOI":"10.1016\/j.bcp.2010.08.012"},{"key":"8_CR12","doi-asserted-by":"crossref","unstructured":"Pewzner-Jung Y, Brenner O, Braun S et al. A critical role for ceramide synthase 2 in liver homeostasis: II. Insights into molecular changes leading to hepatopathy. J Biol Chem 285(14): 10911\u201310923.","DOI":"10.1074\/jbc.M109.077610"},{"key":"8_CR13","doi-asserted-by":"crossref","unstructured":"Pewzner-Jung Y, Park H, Laviad EL et al. A critical role for ceramide synthase 2 in liver homeostasis: I. Alterations in lipid metabolic pathways. J Biol Chem 285(14):10902\u201310910.","DOI":"10.1074\/jbc.M109.077594"},{"key":"8_CR14","doi-asserted-by":"crossref","unstructured":"Yacoub A, Hamed HA, Allegood J et al. PERK-dependent regulation of ceramide synthase 6 and thioredoxin play a key role in mda-7\/IL-24-induced killing of primary human glioblastoma multiforme cells. Cancer Res 70(3): 1120\u20131129.","DOI":"10.1158\/0008-5472.CAN-09-4043"},{"key":"8_CR15","doi-asserted-by":"crossref","unstructured":"Erez-Roman R, Pienik R, Futerman AH. Increased ceramide synthase 2 and 6 mRNA levels in breast cancer tissues and correlation with sphingosine kinase expression. Biochem Biophys Res commun 391(1):219\u2013223.","DOI":"10.1016\/j.bbrc.2009.11.035"},{"issue":"48","key":"8_CR16","doi-asserted-by":"crossref","first-page":"33549","DOI":"10.1074\/jbc.M109.031971","volume":"284","author":"S Imgrund","year":"2009","unstructured":"Imgrund S et al. Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration and hepatocarcinomas. J Biol Chem 2009; 284(48):33549\u201333560.","journal-title":"J Biol Chem"},{"key":"8_CR17","doi-asserted-by":"crossref","unstructured":"Sridevi P, Alexander H, Laviad EL et al. Stress-induced ER to Golgi translocation of ceramide synthase 1 is dependent on proteasomal processing. Exp Cell Res 316(1):78\u201391.","DOI":"10.1016\/j.yexcr.2009.09.027"},{"key":"8_CR18","doi-asserted-by":"crossref","unstructured":"Senkal CE, Ponnusamy S, Bielawski J et al. Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6\/CHOP arm of ER-stress-response pathways. FASEB J 24(1):296\u2013308.","DOI":"10.1096\/fj.09-135087"},{"issue":"7","key":"8_CR19","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/j.bbamcr.2009.04.006","volume":"1793","author":"P Sridevi","year":"2009","unstructured":"Sridevi P, Alexander H, Laviad EL et al. Ceramide synthase 1 is regulated by proteasomal mediated turnover. Biochim Biophys Acta 2009; 1793(7):1218\u20131227.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"8_CR20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/onc.2008.468","volume":"28","author":"S White-Gilbertson","year":"2009","unstructured":"White-Gilbertson S, Mullen T, Senkal C et al. Ceramide synthase 6 modulates TRAIL sensitivity and nuclear translocation of active caspase-3 in colon cancer cells. Oncogene 2009; 28(8): 1132\u20131141.","journal-title":"Oncogene"},{"issue":"8","key":"8_CR21","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1158\/1541-7786.MCR-07-0100","volume":"5","author":"J Min","year":"2007","unstructured":"Min J, Mesika A, Sivaguru M et al. (Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1. Mol Cancer Res 2007; 5(8):801\u2013812.","journal-title":"Mol Cancer Res"},{"issue":"6","key":"8_CR22","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1194\/jlr.M500001-JLR200","volume":"46","author":"Z Xu","year":"2005","unstructured":"Xu Z, Zhou J, McCoy DM et al. LASS5 is the predominant ceramide synthase isoform involved in de novo sphingolipid synthesis in lung epithelia. J Lipid Res 2005; 46(6):1229\u20131238.","journal-title":"J Lipid Res"},{"issue":"2","key":"8_CR23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1042\/BJ20090699","volume":"424","author":"SD Spassieva","year":"2009","unstructured":"Spassieva SD, Mullen TD, Townsend DM et al. Disruption of ceramide synthesis by CerS2 down-regulation leads to autophagy and the unfolded protein response. Biochem J 2009; 424(2):273\u2013283.","journal-title":"Biochem J"},{"issue":"12","key":"8_CR24","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.bbamem.2006.10.018","volume":"1758","author":"TA Taha","year":"2006","unstructured":"Taha TA, Mullen TD, Obeid LM. A house divided: ceramide, sphingosine and sphingosine-1-phosphate in programmed cell death. Biochim Biophys Acta 2006; 1758(12):2027\u20132036.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"8_CR25","first-page":"113","volume":"39","author":"TA Taha","year":"2006","unstructured":"Taha TA, Hannun YA, Obeid LM. Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Biol 2006; 39(2): 113\u2013131.","journal-title":"J Biochem Mol Biol"},{"issue":"43","key":"8_CR26","doi-asserted-by":"crossref","first-page":"13106","DOI":"10.1021\/bi020385t","volume":"41","author":"X Buton","year":"2002","unstructured":"Buton X, Herv\u00e9 P, Kubelt J et al. Transbilayer movement of monohexosylsphingolipids in endoplasmic reticulum and Golgi membranes. Biochemistry 2002; 41(43):13106\u201313115.","journal-title":"Biochemistry"},{"issue":"1","key":"8_CR27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1083\/jcb.200704091","volume":"179","author":"D Halter","year":"2007","unstructured":"Halter D, Neumann S, van Dijk SM et al. Pre-and postGolgi translocation of glucosylceramide in glycosphingolipid synthesis. J Cell Biol 2007; 179(1):101\u2013115.","journal-title":"J Cell Biol"},{"issue":"3","key":"8_CR28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bbagen.2007.08.010","volume":"1780","author":"S Chatterjee","year":"2008","unstructured":"Chatterjee S, Pandey A. The Yin and Yang of lactosylceramide metabolism: implications in cell function. Biochim Biophys Acta 2008; 1780(3):370\u2013382.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"8_CR29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1042\/bst0270409","volume":"27","author":"T Kolter","year":"1999","unstructured":"Kolter T, Doering T, Wilkening G et al. Recent advances in the biochemistry of glycosphingolipid metabolism. Biochem Soc Trans 1999; 27(4):409\u2013415.","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"8_CR30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S0022-2275(20)31670-9","volume":"42","author":"RA Memon","year":"2001","unstructured":"Memon RA, Holleran WM, Uchida Y et al. Regulation of sphingolipid and glycosphingolipid metabolism in extrahepatic tissues by endotoxin. J Lipid Res 2001; 42(3):452\u2013459.","journal-title":"J Lipid Res"},{"issue":"14","key":"8_CR31","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1021\/ac070716d","volume":"79","author":"CD Whitmore","year":"2007","unstructured":"Whitmore CD, Hindsgaul O, Palcic MM et al. Metabolic cytometry. Glycosphingolipid metabolism in single cells. Anal Chem 2007; 79(14):5139\u20135142.","journal-title":"Anal Chem"},{"key":"8_CR32","doi-asserted-by":"crossref","unstructured":"Xu YH, Barnes S, Sun Y et al. Multi-system disorders of glycosphingolipid and ganglioside metabolism. J Lipid Res 51(7):1643\u20131675.","DOI":"10.1194\/jlr.R003996"},{"issue":"4","key":"8_CR33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.semcdb.2004.03.007","volume":"15","author":"S Degroote","year":"2004","unstructured":"Degroote S, Wolthoorn J, van Meer G. The cell biology of glycosphingolipids. Semin Cell Dev Biol 2004; 15(4):375\u2013387.","journal-title":"Semin Cell Dev Biol"},{"issue":"9","key":"8_CR34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1023\/B:GLYC.0000043294.62504.2c","volume":"20","author":"A Morales","year":"2004","unstructured":"Morales A, Colell A, Mari M et al. Glycosphingolipids and mitochondria: role in apoptosis and disease. Glycoconj J 2004; 20(9):579\u2013588.","journal-title":"Glycoconj J"},{"issue":"52","key":"8_CR35","doi-asserted-by":"crossref","first-page":"36265","DOI":"10.1074\/jbc.M805755200","volume":"283","author":"L Anastasia","year":"2008","unstructured":"Anastasia L, Papini N, Colazzo F et al. NEU3 sialidase strictly modulates GM3 levels in skeletal myoblasts C2C12 thus favoring their differentiation and protecting them from apoptosis. J Biol Chem 2008; 283(52):36265\u201336271.","journal-title":"J Biol Chem"},{"issue":"2","key":"8_CR36","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1042\/BJ20070503","volume":"408","author":"G Zanchetti","year":"2007","unstructured":"Zanchetti G, Colombi P, Manzoni M et al. Sialidase NEU3 is a peripheral membrane protein localized on the cell surface and in endosomal structures. Biochem J 2007; 408(2):211\u2013219.","journal-title":"Biochem J"},{"issue":"2","key":"8_CR37","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jmgm.2005.12.006","volume":"25","author":"S Magesh","year":"2006","unstructured":"Magesh S, Suzuki T, Miyagi T et al. Homology modeling of human sialidase enzymes NEU1, NEU3 and NEU4 based on the crystal structure of NEU2: hints for the design of selective NEU3 inhibitors. J Mol Graph Model 2006; 25(2):196\u2013207.","journal-title":"J Mol Graph Model"},{"issue":"29","key":"8_CR38","doi-asserted-by":"crossref","first-page":"26252","DOI":"10.1074\/jbc.M110515200","volume":"277","author":"Y Wang","year":"2002","unstructured":"Wang Y, Yamaguchi K, Wada T et al. A close association of the ganglioside-specific sialidase Neu3 with caveolin in membrane microdomains. J Biol Chem 2002; 277(29):26252\u201326259.","journal-title":"J Biol Chem"},{"key":"8_CR39","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/bj3490343","volume":"349","author":"E Monti","year":"2000","unstructured":"Monti E, Bassi MT, Papini N et al. Identification and expression of NEU3, a novel human sialidase associated to the plasma membrane. Biochem J 2000; 349(Pt 1):343\u2013351.","journal-title":"Biochem J"},{"key":"8_CR40","doi-asserted-by":"crossref","unstructured":"Bigi A, Morosi L, Pozzi C et al. Human sialidase NEU4 long and short are extrinsic proteins bound to outer mitochondrial membrane and the endoplasmic reticulum, respectively. Glycobiology 20(2):148\u2013157.","DOI":"10.1093\/glycob\/cwp156"},{"key":"8_CR41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/BJ20050017","volume":"390","author":"K Yamaguchi","year":"2005","unstructured":"Yamaguchi K, Hata K, Koseki K et al. Evidence for mitochondrial localization of a novel human sialidase (NEU4). Biochem J 2005; 390(Pt 1):85\u201393.","journal-title":"Biochem J"},{"issue":"2\u20133","key":"8_CR42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10545-006-0272-5","volume":"29","author":"JM Aerts","year":"2006","unstructured":"Aerts JM, Hollak CE, Boot RG et al. Substrate reduction therapy of glycosphingolipid storage disorders. J Inherit Metab Dis 2006; 29(2\u20133):449\u2013456.","journal-title":"J Inherit Metab Dis"},{"issue":"12","key":"8_CR43","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.bbamem.2006.05.027","volume":"1758","author":"T Kolter","year":"2006","unstructured":"Kolter T, Sandhoff K. Sphingolipid metabolism diseases. Biochim Biophys Acta 2006;1758(12):2057\u20132079.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"8_CR44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1358\/dot.2006.42.1.937457","volume":"42","author":"RH Lachmann","year":"2006","unstructured":"Lachmann RH. Miglustat: substrate reduction therapy for glycosphingolipid lysosomal storage disorders. Drugs today (Barc) 2006; 42(1):29\u201338.","journal-title":"Drugs today (Barc)"},{"issue":"8","key":"8_CR45","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.braindev.2004.01.005","volume":"26","author":"HA Ozkara","year":"2004","unstructured":"Ozkara HA. Recent advances in the biochemistry and genetics of sphingolipidoses. Brain Dev 2004; 26(8):497\u2013505.","journal-title":"Brain Dev"},{"key":"8_CR46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/0-387-25515-X_21","volume":"564","author":"FM Platt","year":"2005","unstructured":"Platt FM et al. New developments in treating glycosphingolipid storage diseases. Adv Exp Med Biol 2005; 564:117\u2013126.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"8_CR47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/B:GLYC.0000046272.38480.ef","volume":"21","author":"A Raas-Rothschild","year":"2004","unstructured":"Raas-Rothschild A, Pankova-Kholmyansky I, Kacher Yet al. Glycosphingolipidoses: beyond the enzymatic defect. Glycoconj J 2004; 21(6):295\u2013304.","journal-title":"Glycoconj J"},{"issue":"10","key":"8_CR48","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1007\/s00018-005-5437-0","volume":"63","author":"AR Sawkar","year":"2006","unstructured":"Sawkar AR, D\u2019Haeze W, Kelly JW. Therapeutic strategies to ameliorate lysosomal storage disorders\u2014a focus on Gaucher disease. Cell Mol Life Sci 2006; 63(10): 1179\u20131192.","journal-title":"Cell Mol Life Sci"},{"key":"8_CR49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0074-7696(07)62003-8","volume":"262","author":"DJ Sillence","year":"2007","unstructured":"Sillence DJ. New insights into glycosphingolipid functions\u2014storage, lipid rafts and translocators. Int Rev Cytol 2007; 262:151\u2013189.","journal-title":"Int Rev Cytol"},{"issue":"12","key":"8_CR50","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1021\/bi00553a035","volume":"19","author":"TA Brasitus","year":"1980","unstructured":"Brasitus TA, Schachter D. Lipid dynamics and lipid-protein interactions in rat enterocyte basolateral and microvillus membranes. Biochemistry 1980; 19(12):2763\u20132769.","journal-title":"Biochemistry"},{"issue":"1","key":"8_CR51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1042\/bj1090051","volume":"109","author":"GG Forstner","year":"1968","unstructured":"Forstner GG, Tanaka K, Isselbacher KJ. Lipid composition of the isolated rat intestinal microvillus membrane. Biochem J 1968; 109(1):51\u201359.","journal-title":"Biochem J"},{"issue":"2","key":"8_CR52","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0005-2760(74)90253-7","volume":"369","author":"K Kawai","year":"1974","unstructured":"Kawai K, Fujita M, Nakao M. Lipid components of two different regions of an intestinal epithelial cell membrane of mouse. Biochim Biophys Acta 1974; 369(2):222\u2013233.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"8_CR53","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0005-2736(79)90315-8","volume":"558","author":"CD Stubbs","year":"1979","unstructured":"Stubbs CD, Ketterer B, Hicks RM. The isolation and analysis of the luminal plasma membrane of calf urinary bladder epithelium. Biochim Biophys Acta 1979; 558(1):58\u201372.","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20133","key":"8_CR54","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-5793(03)00709-9","volume":"547","author":"A Fanzani","year":"2003","unstructured":"Fanzani A, Giuliani R, Colombo F et al. Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells. FEBS Lett 2003; 547(1\u20133):183\u2013188.","journal-title":"FEBS Lett"},{"issue":"12","key":"8_CR55","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/glycob\/9.12.1313","volume":"9","author":"E Monti","year":"1999","unstructured":"Monti E, Preti A, Nesti C et al. Expression of a novel human sialidase encoded by the NEU2 gene. Glycobiology 1999; 9(12):1313\u20131321.","journal-title":"Glycobiology"},{"issue":"1","key":"8_CR56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/geno.1999.5749","volume":"57","author":"E Monti","year":"1999","unstructured":"Monti E, Preti A, Rossi E et al. Cloning and characterization of NEU2, a human gene homologous to rodent soluble sialidases. Genomics 1999; 57(1):137\u2013143.","journal-title":"Genomics"},{"issue":"17","key":"8_CR57","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1016\/S0021-9258(19)49798-6","volume":"267","author":"WW Young Jr","year":"1992","unstructured":"Young WW Jr Lutz MS, Blackburn WA. Endogenous glycosphingolipids move to the cell surface at a rate consistent with bulk flow estimates. J Biol Chem 1992; 267(17): 12011\u201312015.","journal-title":"J Biol Chem"},{"issue":"29","key":"8_CR58","doi-asserted-by":"crossref","first-page":"25855","DOI":"10.1074\/jbc.R200010200","volume":"277","author":"G Meer van","year":"2002","unstructured":"van Meer G, Lisman Q. Sphingolipid transport: rafts and translocators. J Biol Chem 2002; 277(29):25855\u201325858.","journal-title":"J Biol Chem"},{"issue":"12","key":"8_CR59","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0962-8924(02)02399-1","volume":"12","author":"DL Marks","year":"2002","unstructured":"Marks DL, Pagano RE. Endocytosis and sorting of glycosphingolipids in sphingolipid storage disease. Trends Cell Biol 2002; 12(12):605\u2013613.","journal-title":"Trends Cell Biol"},{"issue":"4","key":"8_CR60","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1083\/jcb.105.4.1623","volume":"105","author":"G Meer van","year":"1987","unstructured":"van Meer G, Stelzer EH, Wijnaendts-van-Resandt RW et al. Sorting of sphingolipids in epithelial (Madin-Darby canine kidney) cells. J Cell Biol 1987; 105(4):1623\u20131635.","journal-title":"J Cell Biol"},{"issue":"9","key":"8_CR61","doi-asserted-by":"crossref","first-page":"7564","DOI":"10.1074\/jbc.M210457200","volume":"278","author":"DK Sharma","year":"2003","unstructured":"Sharma DK, Choudhury A, Singh RD et al. Glycosphingolipids internalized via caveolar-related endocytosis rapidly merge with the clathrin pathway in early endosomes and form microdomains for recycling. J Biol Chem 2003; 278(9):7564\u20137572.","journal-title":"J Biol Chem"},{"issue":"8","key":"8_CR62","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1091\/mbc.e02-12-0809","volume":"14","author":"RD Singh","year":"2003","unstructured":"Singh RD, Puri V, Valiyaveettil JT et al. Selective caveolin-1-dependent endocytosis of glycosphingolipids. Mol Biol cell 2003; 14(8):3254\u20133265.","journal-title":"Mol Biol cell"},{"issue":"7","key":"8_CR63","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1073\/pnas.91.7.2708","volume":"91","author":"DE Warnock","year":"1994","unstructured":"Warnock DE, Lutz MS, Blackburn WA et al. Transport of newly synthesized glucosylceramide to the plasma membrane by a nonGolgi pathway. Proc Natl Acad Sci USA 1994; 91(7):2708\u20132712.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"8_CR64","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1074\/jbc.275.7.5104","volume":"275","author":"X Lin","year":"2000","unstructured":"Lin X, Mattjus P, Pike HM et al. Cloning and expression of glycolipid transfer protein from bovine and porcine brain. J Biol Chem 2000; 275(7):5104\u20135110.","journal-title":"J Biol Chem"},{"key":"8_CR65","doi-asserted-by":"crossref","unstructured":"Gupta G, Surolia A. Glycosphingolipids in microdomain formation and their spatial organization. FEBS Lett 584(9): 1634\u20131641.","DOI":"10.1016\/j.febslet.2009.11.070"},{"key":"8_CR66","doi-asserted-by":"crossref","unstructured":"Igarashi Y, Kannagi R. Glycosphingolipids as mediators of phenotypic changes associated with development and cancer progression. J Biochem 147(1):3\u20138.","DOI":"10.1093\/jb\/mvp195"},{"key":"8_CR67","doi-asserted-by":"crossref","unstructured":"Sonnino S, Aureli M, Loberto N et al. Fine tuning of cell functions through remodeling of glycosphingolipids by plasma membrane-associated glycohydrolases. FEBS Lett 584(9):1914\u20131922.","DOI":"10.1016\/j.febslet.2009.11.020"},{"issue":"18","key":"8_CR68","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1073\/pnas.0902368106","volume":"106","author":"F Guan","year":"2009","unstructured":"Guan F, Handa K, Hakomori SI. Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines. Proc Natl Acad Sci USA 2009; 106(18):7461\u20137466.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"8_CR69","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3858\/emm.2009.41.12.099","volume":"41","author":"JU Jung","year":"2009","unstructured":"Jung JU, Ko K, Lee DH et al. The roles of glycosphingolipids in the proliferation and neural differentiation of mouse embryonic stem cells. Exp Mol Med 2009; 41(12):935\u2013945.","journal-title":"Exp Mol Med"},{"issue":"3\u20134","key":"8_CR70","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.plipres.2009.03.002","volume":"48","author":"M Langeveld","year":"2009","unstructured":"Langeveld M, Aerts JM. Glycosphingolipids and insulin resistance. Prog Lipid Res 2009; 48(3\u20134):196\u2013205.","journal-title":"Prog Lipid Res"},{"issue":"6","key":"8_CR71","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10719-008-9215-8","volume":"26","author":"S Sonnino","year":"2009","unstructured":"Sonnino S et al. Role of very long fatty acid-containing glycosphingolipids in membrane organization and cell signaling: the model of lactosylceramide in neutrophils. Glycoconj J 2009; 26(6):615\u2013621.","journal-title":"Glycoconj J"},{"issue":"47","key":"8_CR72","doi-asserted-by":"crossref","first-page":"8848","DOI":"10.1002\/anie.200902620","volume":"48","author":"T Wennekes","year":"2009","unstructured":"Wennekes T et al. Glycosphingolipids\u2014nature, function and pharmacological modulation. Angew Chem Int Ed Engl 2009; 48(47):8848\u20138869.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"8_CR73","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbamem.2008.11.010","volume":"1788","author":"B Westerlund","year":"2009","unstructured":"Westerlund B, Slotte JP. How the molecular features of glycosphingolipids affect domain formation in fluid membranes. Biochim Biophys Acta 2009; 1788(1):194\u2013201.","journal-title":"Biochim Biophys Acta"},{"key":"8_CR74","doi-asserted-by":"crossref","unstructured":"Takiar V, Caplan MJ. Telling kidneys to cease and decyst. Nat Med 16(7):751\u2013752.","DOI":"10.1038\/nm0710-751"},{"key":"8_CR75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ijc.2910570727","volume":"8","author":"C Gnewuch","year":"1994","unstructured":"Gnewuch C, Jaques G, Havemann K et al. Re-assessment of acidic glycosphingolipids in small-cell-lung-cancer tissues and cell lines. Int J cancer Suppl 1994; 8:125\u2013126.","journal-title":"Int J cancer Suppl"},{"issue":"12","key":"8_CR76","first-page":"461","volume":"3","author":"S Hakomori","year":"1991","unstructured":"Hakomori S. New directions in cancer therapy based on aberrant expression of glycosphingolipids: anti-adhesion and ortho-signaling therapy. Cancer cells 1991; 3(12):461\u2013470.","journal-title":"Cancer cells"},{"issue":"9","key":"8_CR77","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/glycob\/cwp083","volume":"19","author":"K Shida","year":"2009","unstructured":"Shida K, Misonou Y, Korekane H et al. Unusual accumulation of sulfated glycosphingolipids in colon cancer cells. Glycobiology 2009; 19(9):1018\u20131033.","journal-title":"Glycobiology"},{"issue":"1","key":"8_CR78","first-page":"113","volume":"6","author":"M Suzuki","year":"1999","unstructured":"Suzuki M, Ando O, Ohta T et al. High expression of glycosphingolipids involved in procoagulant activity of cancer cells. Oncol Rep 1999; 6(1):113\u2013115.","journal-title":"Oncol Rep"},{"issue":"6","key":"8_CR79","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1023\/B:GLYC.0000046274.35732.47","volume":"21","author":"E Bieberich","year":"2004","unstructured":"Bieberich E. Integration of glycosphingolipid metabolism and cell-fate decisions in cancer and stem cells: review and hypothesis. Glycoconj J 2004; 21(6):315\u2013327.","journal-title":"Glycoconj J"},{"issue":"2","key":"8_CR80","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-5793(96)00942-8","volume":"394","author":"MC Cabot","year":"1996","unstructured":"Cabot MC, Giuliano AE, Volner A et al. Tamoxifen retards glycosphingolipid metabolism in human cancer cells. FEBS Lett 1996; 394(2):129\u2013131.","journal-title":"FEBS Lett"},{"issue":"12","key":"8_CR81","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.bbamem.2006.08.012","volume":"1758","author":"V Gouaze-Andersson","year":"2006","unstructured":"Gouaze-Andersson V, Cabot MC. Glycosphingolipids and drug resistance. Biochim Biophys Acta 2006; 1758(12):2096\u20132103.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"8_CR82","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/bcr1841","volume":"10","author":"Y Gu","year":"2008","unstructured":"Gu Y, Zhang J, Mi W et al. Silencing of GM3 synthase suppresses lung metastasis of murine breast cancer cells. Breast Cancer Res 2008; 10(1):R1.","journal-title":"Breast Cancer Res"},{"issue":"1\u20134","key":"8_CR83","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000046451","volume":"161","author":"S Hakomori","year":"1998","unstructured":"Hakomori S. Cancer-associated glycosphingolipid antigens: their structure, organization and function. Acta Anat (Basel) 1998; 161(1\u20134):79\u201390.","journal-title":"Acta Anat (Basel)"},{"issue":"52","key":"8_CR84","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1073\/pnas.0506474102","volume":"102","author":"O Kovbasnjuk","year":"2005","unstructured":"Kovbasnjuk O, Mourtazina R, Baibakov B et al. The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proc Natl Acad Sci USA 2005; 102(52):19087\u201319092.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"8_CR85","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1074\/jbc.272.3.1682","volume":"272","author":"Y Lavie","year":"1997","unstructured":"Lavie Y et al. Agents that reverse multidrug resistance, tamoxifen, verapamil and cyclosporin A, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells. J Biol Chem 1997; 272(3): 1682\u20131687.","journal-title":"J Biol Chem"},{"key":"8_CR86","doi-asserted-by":"crossref","unstructured":"Messner MC, Cabot MC. Glucosylceramide in humans. Adv Exp Med Biol 688:156\u2013164.","DOI":"10.1007\/978-1-4419-6741-1_11"},{"issue":"3","key":"8_CR87","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbagen.2007.09.016","volume":"1780","author":"T Miyagi","year":"2008","unstructured":"Miyagi T, Wada T, Yamaguchi K. Roles of plasma membrane-associated sialidase NEU3 inhuman cancers. Biochim Biophys Acta 2008; 1780(3):532\u2013537.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"8_CR88","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/138955707780363792","volume":"7","author":"A Morales","year":"2007","unstructured":"Morales A, Fernandez-Checa JC. Pharmacological modulation of sphingolipids and role in disease and cancer cell biology. Mini Rev Med Chem 2007; 7(4):371\u2013382.","journal-title":"Mini Rev Med Chem"},{"issue":"6","key":"8_CR89","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0006-2952(98)00274-3","volume":"57","author":"NS Radin","year":"1999","unstructured":"Radin NS. Chemotherapy by slowing glucosphingolipid synthesis. Biochem Pharmacol 1999; 57(6):589\u2013595.","journal-title":"Biochem Pharmacol"},{"key":"8_CR90","doi-asserted-by":"crossref","unstructured":"Shida K, Korekane H, Misonou Y et al. Novel ganglioside found in adenocarcinoma cells of Lewis-negative patients. Glycobiology 20(12):1594\u20131606.","DOI":"10.1093\/glycob\/cwq108"},{"issue":"1","key":"8_CR91","first-page":"3","volume":"34","author":"X Zhang","year":"2004","unstructured":"Zhang X, Kiechle FL. Review: glycosphingolipids in health and disease. Ann Clin Lab Sci 2004; 34(1):3\u201313.","journal-title":"Ann Clin Lab Sci"},{"key":"8_CR92","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0076-6879(03)01059-0","volume":"363","author":"S Chatterjee","year":"2003","unstructured":"Chatterjee S, Wei H. Roles of glycosphingolipids in cell signaling: adhesion, migration and proliferation. Methods Enzymol 2003; 363:300\u2013312.","journal-title":"Methods Enzymol"},{"issue":"1","key":"8_CR93","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3181\/00379727-166-41031","volume":"166","author":"PM Kimball","year":"1981","unstructured":"Kimball PM, Hammonds L, McKibbin JM et al. In vitro effects of glycosphingolipids on human tumor cell proliferation. Proc Soc Exp Biol Med 1981; 166(1):107\u2013112.","journal-title":"Proc Soc Exp Biol Med"},{"issue":"19","key":"8_CR94","doi-asserted-by":"crossref","first-page":"16396","DOI":"10.1074\/jbc.M200877200","volume":"277","author":"AK Bhunia","year":"2002","unstructured":"Bhunia AK, Schwarzmann G, Chatterjee S. GD3 recruits reactive oxygen species to induce cell proliferation and apoptosis in human aortic smooth muscle cells. J Biol Chem 2002; 277(19):16396\u201316402.","journal-title":"J Biol Chem"},{"issue":"1","key":"8_CR95","first-page":"191","volume":"26","author":"M Nishio","year":"2005","unstructured":"Nishio M, Tajima O, Furukawa K et al. Over-expression of GM1 enhances cell proliferation with epidermal growth factor without affecting the receptor localization in the microdomain in PC12 cells. Int J Oncol 2005; 26(1): 191\u2013199.","journal-title":"Int J Oncol"},{"issue":"14","key":"8_CR96","doi-asserted-by":"crossref","first-page":"13742","DOI":"10.1074\/jbc.M411959200","volume":"280","author":"R Pannu","year":"2005","unstructured":"Pannu R, Singh AK, Singh I. A novel role of lactosylceramide in the regulation of tumor necrosis factor alpha-mediated proliferation of rat primary astrocytes. Implications for astrogliosis following neurotrauma. J Biol Chem 2005; 280(14):13742\u201313751.","journal-title":"J Biol Chem"},{"issue":"4","key":"8_CR97","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1471-4159.2004.02750.x","volume":"91","author":"M Yanagisawa","year":"2004","unstructured":"Yanagisawa M, Liour SS, Yu RK. Involvement of gangliosides in proliferation of immortalized neural progenitor cells. J Neurochem 2004; 91(4):804\u2013812.","journal-title":"J Neurochem"},{"issue":"1\u20132","key":"8_CR98","first-page":"56","volume":"34","author":"S Chatterjee","year":"1997","unstructured":"Chatterjee S. Oxidized low density lipoproteins and lactosylceramide both stimulate the expression of proliferating cell nuclear antigen and the proliferation of aortic smooth muscle cells. Indian J Biochem Biophys 1997; 34(1\u20132):56\u201360.","journal-title":"Indian J Biochem Biophys"},{"issue":"6","key":"8_CR99","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0022-2275(20)39163-X","volume":"37","author":"S Chatterjee","year":"1996","unstructured":"Chatterjee S, Shi WY, Wilson P et al. Role of lactosylceramide and MAP kinase in the proliferation of proximal tubular cells in human polycystic kidney disease. J Lipid Res 1996; 37(6): 1334\u20131344.","journal-title":"J Lipid Res"},{"issue":"7","key":"8_CR100","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/biot.200800322","volume":"4","author":"FB Ozbayraktar","year":"2009","unstructured":"Ozbayraktar FB, Ulgen KO. Molecular facets of sphingolipids: mediators of diseases. Biotechnol J 2009; 4(7):1028\u20131041.","journal-title":"Biotechnol J"},{"issue":"2","key":"8_CR101","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1074\/jbc.274.2.1140","volume":"274","author":"YY Liu","year":"1999","unstructured":"Liu YY, Han TY, Giuliano AE et al. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J Biol Chem 1999; 274(2):1140\u20131146.","journal-title":"J Biol Chem"},{"issue":"5","key":"8_CR102","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1194\/jlr.M300486-JLR200","volume":"45","author":"YY Liu","year":"2004","unstructured":"Liu YY, Han TY, Yu JY et al. Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells. J Lipid Res 2004; 45(5):933\u2013940.","journal-title":"J Lipid Res"},{"issue":"1\u20133","key":"8_CR103","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-5793(02)03140-X","volume":"526","author":"A Colell","year":"2002","unstructured":"Colell A, Morales A, Fern\u00e1ndez-Checa JC et al. Ceramide generated by acidic sphingomyelinase contributes to tumor necrosis factor-alpha-mediated apoptosis in human colonHT-29 cells through glycosphingolipids formation. Possible role of ganglioside GD3. FEBS Lett 2002; 526(1\u20133):135\u2013141.","journal-title":"FEBS Lett"},{"issue":"5332","key":"8_CR104","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1126\/science.277.5332.1652","volume":"277","author":"R Maria De","year":"1997","unstructured":"De Maria R, Lenti L, Malisan F et al. Requirement for GD3 ganglioside in CD95-and ceramide-induced apoptosis. Science 1997; 277(5332): 1652\u20131655.","journal-title":"Science"},{"issue":"2\u20133","key":"8_CR105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1388-1981(02)00339-6","volume":"1585","author":"F Malisan","year":"2002","unstructured":"Malisan F, Testi R. GD3 ganglioside and apoptosis. Biochim Biophys Acta 2002; 1585(2\u20133):179\u2013187.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"8_CR106","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.febslet.2006.12.046","volume":"581","author":"T Hasegawa","year":"2007","unstructured":"Hasegawa T, Sugeno N, Takeda A et al. Role of Neu4L sialidase and its substrate ganglioside GD3 in neuronal apoptosis induced by catechol metabolites. FEBS Lett 2007; 581(3):406\u2013412.","journal-title":"FEBS Lett"},{"issue":"10","key":"8_CR107","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s11064-006-9147-2","volume":"31","author":"OM Omran","year":"2006","unstructured":"Omran OM, Saqr HE, Yates AJ. Molecular mechanisms of GD3-induced apoptosis in U-1242 MG glioma cells. Neurochem Res 2006; 31(10):1171\u20131180.","journal-title":"Neurochem Res"},{"issue":"5","key":"8_CR108","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1471-4159.2005.03640.x","volume":"96","author":"HE Saqr","year":"2006","unstructured":"Saqr HE, Omran O, Dasgupta S et al. Endogenous GD3 ganglioside induces apoptosis in U-1242 MG glioma cells. J Neurochem 2006; 96(5):1301\u20131314.","journal-title":"J Neurochem"},{"issue":"1\u20133","key":"8_CR109","first-page":"183","volume":"568","author":"KT Ha","year":"2004","unstructured":"Ha KT, Lee YC, Kim CH. Overexpression of GD3 synthase induces apoptosis of vascular endothelial ECV304 cells through downregulation of Bcl-2. FEBS Lett 2004; 568(1\u20133): 183\u2013187.","journal-title":"FEBS Lett"},{"issue":"10\u201311","key":"8_CR110","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0531-5565(02)00138-9","volume":"37","author":"F Malisan","year":"2002","unstructured":"Malisan F, Testi R. GD3 in cellular ageing and apoptosis. Exp Gerontol 2002; 37(10\u201311): 1273\u20131282.","journal-title":"Exp Gerontol"},{"issue":"1","key":"8_CR111","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-5793(01)02776-4","volume":"506","author":"AM Giammarioli","year":"2001","unstructured":"Giammarioli AM, Garofalo T, Sorice M et al. GD3 glycosphingolipid contributes to Fas-mediated apoptosis via association with ezrin cytoskeletal protein. FEBS Lett 2001; 506(1):45\u201350.","journal-title":"FEBS Lett"},{"issue":"6","key":"8_CR112","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1096\/fj.00-0574fje","volume":"15","author":"A Colell","year":"2001","unstructured":"Colell A, Garc\u00eda-Ruiz C, Roman J et al. Ganglioside GD3 enhances apoptosis by suppressing the nuclear factor-kappa B-dependent survival pathway. FASEB J 2001; 15(6): 1068\u20131070.","journal-title":"FASEB J"},{"issue":"3","key":"8_CR113","first-page":"487","volume":"11","author":"MR Rippo","year":"2000","unstructured":"Rippo MR, Malisan F, Ravagnan L et al. GD3 ganglioside as an intracellular mediator of apoptosis. Eur Cytokine Netw 2000; 11(3):487\u2013488.","journal-title":"Eur Cytokine Netw"},{"key":"8_CR114","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1749-6632.1999.tb07846.x","volume":"893","author":"BS Kristal","year":"1999","unstructured":"Kristal BS, Brown AM. Ganglioside GD3, the mitochondrial permeability transition and apoptosis. Ann N Y Acad Sci 1999; 893:321\u2013324.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"8_CR115","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/002215540004800106","volume":"48","author":"F Farina","year":"2000","unstructured":"Farina F, Cappello F, Todaro M et al. Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in farber disease. J Histochem Cytochem 2000; 48(1):57\u201362.","journal-title":"J Histochem Cytochem"},{"issue":"32","key":"8_CR116","doi-asserted-by":"crossref","first-page":"22581","DOI":"10.1074\/jbc.274.32.22581","volume":"274","author":"L Scorrano","year":"1999","unstructured":"Scorrano L, Petronilli V, Di Lisa F et al. Commitment to apoptosis by GD3 ganglioside depends on opening of the mitochondrial permeability transition pore. J Biol Chem 1999; 274(32):22581\u201322585.","journal-title":"J Biol Chem"},{"issue":"6","key":"8_CR117","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1084\/jem.187.6.897","volume":"187","author":"R Maria De","year":"1998","unstructured":"De Maria R, Rippo MR, Schuchman EH et al. Acidic sphingomyelinase (ASM) is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells. J Exp Med 1998; 187(6): 897\u2013902.","journal-title":"J Exp Med"},{"issue":"3\u20134","key":"8_CR118","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1023\/A:1026524820177","volume":"17","author":"SI Hakomori","year":"2000","unstructured":"Hakomori SI. Cell adhesion\/recognition and signal transduction through glycosphingolipid microdomain. Glycoconj J 2000; 17(3\u20134):143\u2013151.","journal-title":"Glycoconj J"},{"issue":"5","key":"8_CR119","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1023\/A:1005454602454","volume":"21","author":"P Fredman","year":"1998","unstructured":"Fredman P. Sphingolipids and cell signalling. J Inherit Metab Dis 1998; 21(5):472\u2013480.","journal-title":"J Inherit Metab Dis"},{"issue":"31","key":"8_CR120","doi-asserted-by":"crossref","first-page":"18713","DOI":"10.1016\/S0021-9258(17)30565-3","volume":"265","author":"S Hakomori","year":"1990","unstructured":"Hakomori S. Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J Biol Chem 1990; 265(31):18713\u201318716.","journal-title":"J Biol Chem"},{"issue":"6","key":"8_CR121","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/oxfordjournals.jbchem.a124992","volume":"118","author":"S Hakomori","year":"1995","unstructured":"Hakomori S, Igarashi Y. Functional role of glycosphingolipids in cell recognition and signaling. J Biochem 1995; 118(6):1091\u20131103.","journal-title":"J Biochem"},{"issue":"10","key":"8_CR122","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/glycob\/cwg094","volume":"13","author":"H Ideo","year":"2003","unstructured":"Ideo H, Seko A, Ishizuka I et al. The N-terminal carbohydrate recognition domain of galectin-8 recognizes specific glycosphingolipids with high affinity. Glycobiology 2003; 13(10):713\u2013723.","journal-title":"Glycobiology"},{"issue":"6","key":"8_CR123","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1074\/jbc.M410362200","volume":"280","author":"H Ideo","year":"2005","unstructured":"Ideo H, Seko A, Yamashita K. Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells. J Biol Chem 2005; 280(6): 4730\u20134737.","journal-title":"J Biol Chem"},{"issue":"7032","key":"8_CR124","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature03407","volume":"434","author":"Y Kinjo","year":"2005","unstructured":"Kinjo Y, Wu D, Kim G et al. Recognition of bacterial glycosphingolipids by natural killer T-cells. Nature 2005; 434(7032):520\u2013525.","journal-title":"Nature"},{"issue":"5","key":"8_CR125","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.micinf.2007.01.023","volume":"9","author":"N Roche","year":"2007","unstructured":"Roche N, Ilver D, Angstr\u00f6m J et al. Human gastric glycosphingolipids recognized by Helicobacter pylori vacuolating cytotoxin VacA. Microbes Infect 2007; 9(5):605\u2013614.","journal-title":"Microbes Infect"},{"issue":"5","key":"8_CR126","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/glycob\/1.5.477","volume":"1","author":"RL Schnaar","year":"1991","unstructured":"Schnaar RL. Glycosphingolipids in cell surface recognition. Glycobiology 1991; 1(5):477\u2013485.","journal-title":"Glycobiology"},{"issue":"5","key":"8_CR127","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.sbi.2009.06.001","volume":"19","author":"PH Lopez","year":"2009","unstructured":"Lopez PH, Schnaar RL. Gangliosides in cell recognition and membrane protein regulation. Curr Opin Struct Biol 2009; 19(5):549\u2013557.","journal-title":"Curr Opin Struct Biol"},{"issue":"Suppl 1","key":"8_CR128","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1471-4159.2007.04822.x","volume":"103","author":"JS Won","year":"2007","unstructured":"Won JS, Singh AK, Singh I. Lactosylceramide: a lipid second messenger in neuroinflammatory disease. J Neurochem 2007; 103Suppl 1:180\u2013191.","journal-title":"J Neurochem"},{"issue":"9647","key":"8_CR129","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","volume":"372","author":"YA Zarate","year":"2008","unstructured":"Zarate YA, Hopkin RJ. Fabry\u2019s disease. Lancet 2008; 372(9647): 1427\u20131435.","journal-title":"Lancet"},{"issue":"4","key":"8_CR130","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1476-5381.2009.00281.x","volume":"158","author":"GF Nixon","year":"2009","unstructured":"Nixon GF. Sphingolipids in inflammation: pathological implications and potential therapeutic targets. Br J Pharmacol 2009; 158(4):982\u2013993.","journal-title":"Br J Pharmacol"},{"issue":"19","key":"8_CR131","doi-asserted-by":"crossref","first-page":"12979","DOI":"10.1074\/jbc.M809500200","volume":"284","author":"K Kitatani","year":"2009","unstructured":"Kitatani K, Sheldon K, Anelli V et al. Acid beta-glucosidase 1 counteracts p38delta-dependent induction of interleukin-6: possible role for ceramide as an anti-inflammatory lipid. J Biol Chem 2009; 284(19):12979\u201312988.","journal-title":"J Biol Chem"},{"issue":"3","key":"8_CR132","doi-asserted-by":"crossref","first-page":"e4723","DOI":"10.1371\/journal.pone.0004723","volume":"4","author":"M Eijk van","year":"2009","unstructured":"van Eijk M, Aten J, Bijl N et al. Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation. PLoS One 2009; 4(3):e4723.","journal-title":"PLoS One"},{"issue":"23","key":"8_CR133","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1016\/j.febslet.2006.06.025","volume":"580","author":"DE Vance","year":"2006","unstructured":"Vance DE. Fundamental research is the basis for understanding and treatment of many human diseases. FEBS Lett 2006; 580(23):5430\u20135435.","journal-title":"FEBS Lett"},{"issue":"Suppl 2","key":"8_CR134","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1023\/A:1012423924648","volume":"24","author":"A Sessa","year":"2001","unstructured":"Sessa A, Meroni M, Battini G et al. Renal pathological changes in fabry disease. J Inherit Metab Dis 2001; 24Suppl 2:66\u201370; discussion 65.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"8_CR135","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1053\/j.ajkd.2003.10.002","volume":"42","author":"D Rizk","year":"2003","unstructured":"Rizk D, Chapman AB. Cystic and inherited kidney diseases. Am J Kidney Dis 2003; 42(6):1305\u20131317.","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"8_CR136","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1023\/A:1012475908718","volume":"24","author":"JP Gr\u00fcnfeld","year":"2001","unstructured":"Gr\u00fcnfeld JP, Lidove O, Joly D et al. Renal disease in Fabry patients. J Inherit Metab Dis 2001; 24Suppl 2:71\u201374; discussion 65.","journal-title":"J Inherit Metab Dis"},{"key":"8_CR137","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000060188","volume":"136","author":"JP Grunfeld","year":"2001","unstructured":"Grunfeld JP, Lidove O, Barbey F. Heterozygotes with Fabry\u2019s disease. Contrib Nephrol 2001; 136:208\u2013210.","journal-title":"Contrib Nephrol"},{"issue":"3","key":"8_CR138","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1681\/ASN.2006080822","volume":"18","author":"EI Christensen","year":"2007","unstructured":"Christensen EI, Zhou Q, S\u00f8rensen SS et al. Distribution of alpha-galactosidase A in normal human kidney and renal accumulation and distribution of recombinant alpha-galactosidase A in Fabry mice. J Am Soc Nephrol 2007; 18(3):698\u2013706.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"8_CR139","first-page":"32","volume":"21","author":"F Breunig","year":"2008","unstructured":"Breunig F, Wanner C. Update on fabry disease: kidney involvement, renal progression and enzyme replacement therapy. J Nephrol 2008; 21(1):32\u201337.","journal-title":"J Nephrol"},{"key":"8_CR140","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000060211","volume":"136","author":"A Sessa","year":"2001","unstructured":"Sessa A, Meroni M, Righetti M et al. Autosomal recessive polycystic kidney disease. Contrib Nephrol 2001; 136:50\u201356.","journal-title":"Contrib Nephrol"},{"key":"8_CR141","unstructured":"Natoli TA, Smith LA, Rogers KA et al. Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models. Nat Med."},{"issue":"8","key":"8_CR142","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.4049\/jimmunol.0900259","volume":"183","author":"S Biswas","year":"2009","unstructured":"Biswas S, Biswas K, Richmond A et al. Elevated levels of select gangliosides in T-cells from renal cell carcinoma patients is associated with T-cell dysfunction. J Immunol 2009; 183(8):5050\u20135058.","journal-title":"J Immunol"},{"key":"8_CR143","doi-asserted-by":"crossref","unstructured":"Scursoni AM, Galluzzo L, Camarero S et al. Detection and characterization of N-glycolyated gangliosides in Wilms tumor by immunohistochemistry. Pediatr Dev Pathol 13(1): 18\u201323.","DOI":"10.2350\/08-10-0544.1"},{"issue":"6","key":"8_CR144","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1158\/0008-5472.CAN-07-6037","volume":"68","author":"T Das","year":"2008","unstructured":"Das T, Sa G, Hilston C et al. GM1 and tumor necrosis factor-alpha, overexpressed in renal cell carcinoma, synergize to induce t-cell apoptosis. Cancer Res 2008; 68(6):2014\u20132023.","journal-title":"Cancer Res"},{"issue":"13","key":"8_CR145","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1158\/0008-5472.CAN-06-0250","volume":"66","author":"K Biswas","year":"2006","unstructured":"Biswas K, Richmond A, Rayman P et al. GM2 expression in renal cell carcinoma: potential role in tumor-induced T-cell dysfunction. Cancer Res 2006; 66(13):6816\u20136825.","journal-title":"Cancer Res"},{"issue":"3","key":"8_CR146","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1042\/BJ20061118","volume":"402","author":"M Senda","year":"2007","unstructured":"Senda M, Ito A, Tsuchida A et al. Identification and expression of a sialyltransferase responsible for the synthesis of disialylgalactosylgloboside in normal and malignant kidney cells: downregulation of ST6GalNAc VI in renal cancers. Biochem J 2007; 402(3):459\u2013470.","journal-title":"Biochem J"},{"issue":"10","key":"8_CR147","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2183\/pjab.84.407","volume":"84","author":"T Miyagi","year":"2008","unstructured":"Miyagi T. Aberrant expression of sialidase and cancer progression. Proc Jpn Acad Ser B Phys Biol Sci 2008;84(10):407\u2013418.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"issue":"16","key":"8_CR148","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1002\/pmic.200800248","volume":"8","author":"T Miyagi","year":"2008","unstructured":"Miyagi T, Wada T, Yamaguchi K et al. Human sialidase as a cancer marker. Proteomics 2008; 8(16):3303\u20133311.","journal-title":"Proteomics"},{"issue":"6C","key":"8_CR149","first-page":"4345","volume":"27","author":"R Maruyama","year":"2007","unstructured":"Maruyama R, Saito S, Bilim V et al. High incidence of GalNAc disialosyl lactotetraosylceramide in metastatic renal cell carcinoma. Anticancer Res 2007; 27(6C):4345\u20134350.","journal-title":"Anticancer Res"},{"issue":"7","key":"8_CR150","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1158\/0008-5472.CAN-08-3776","volume":"69","author":"G Sa","year":"2009","unstructured":"Sa G, Das T, Moon C et al. GD3, an overexpressed tumor-derived ganglioside, mediates the apoptosis of activated but not resting T-cells. Cancer Res 2009; 69(7):3095\u20133104.","journal-title":"Cancer Res"},{"issue":"5","key":"8_CR151","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1084\/jem.148.5.1198","volume":"148","author":"BS Andrews","year":"1978","unstructured":"Andrews BS, Eisenberg RA, Theofilopoulos AN et al. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 1978; 148(5):1198\u20131215.","journal-title":"J Exp Med"},{"issue":"2","key":"8_CR152","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ndt\/gfh633","volume":"20","author":"HS Lee","year":"2005","unstructured":"Lee HS, Lee MS, Lee SM et al. Histological grading of IgA nephropathy predicting renal outcome: revisiting H. S. Lee\u2019s glomerular grading system. Nephrol Dial transplant 2005; 20(2):342\u2013348.","journal-title":"Nephrol Dial transplant"},{"key":"8_CR153","doi-asserted-by":"crossref","unstructured":"Vogtl\u00e4nder NP, van der Vlag J, Bakker MA et al. Expression of sialidase and dystroglycan in human glomerular diseases. Nephrol Dial transplant 25(2):478\u2013484.","DOI":"10.1093\/ndt\/gfp465"},{"issue":"6","key":"8_CR154","doi-asserted-by":"crossref","first-page":"e5979","DOI":"10.1371\/journal.pone.0005979","volume":"4","author":"NP Vogtl\u00e4nder","year":"2009","unstructured":"Vogtl\u00e4nder NP, Visch HJ, Bakker MA et al. Ligation of alpha-dystroglycan on podocytes induces intracellular signaling: a new mechanism forpodocyte effacement? PLoS One 2009; 4(6):e5979.","journal-title":"PLoS One"},{"issue":"2","key":"8_CR155","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0014-5793(86)80985-1","volume":"206","author":"T Miyagi","year":"1986","unstructured":"Miyagi T, Tsuiki S. Evidence for sialidase hydrolyzing gangliosides GM2 and GM1 in rat liver plasma membrane. FEBS Lett 1986; 206(2):223\u2013228.","journal-title":"FEBS Lett"},{"issue":"3","key":"8_CR156","first-page":"375","volume":"42","author":"YS Kanwar","year":"1980","unstructured":"Kanwar YS, Farquhar MG. Detachment of endothelium and epithelium from the glomerular basement membrane produced by kidney perfusion with neuraminidase. Lab Invest 1980; 42(3):375\u2013384.","journal-title":"Lab Invest"},{"issue":"5","key":"8_CR157","first-page":"907","volume":"74","author":"H Gelberg","year":"1996","unstructured":"Gelberg H, Healy L, Whiteley H et al. In vivo enzymatic removal of alpha 2\u21926-linked sialic acid from the glomerular filtration barrier results in podocyte charge alteration and glomerular injury. Lab Invest 1996; 74(5):907\u2013920.","journal-title":"Lab Invest"},{"issue":"8","key":"8_CR158","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1681\/ASN.V1281589","volume":"12","author":"RA Orlando","year":"2001","unstructured":"Orlando RA, Takeda T, Zak B et al. The glomerular epithelial cell anti-adhesin podocalyxin associates with the actin cytoskeleton through interactions with ezrin. J Am Soc Nephrol 2001; 12(8):1589\u20131598.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"8_CR159","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ki.1979.49","volume":"15","author":"PM Andrews","year":"1979","unstructured":"Andrews PM. Glomerular epithelial alterations resulting from sialic acid surface coat removal. Kidney Int 1979; 15(4):376\u2013385.","journal-title":"Kidney Int"},{"issue":"6","key":"8_CR160","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1172\/JCI30954","volume":"117","author":"B Galeano","year":"2007","unstructured":"Galeano B, Klootwijk R, Manoli I et al. Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamine. J Clin Invest 2007; 117(6): 1585\u20131594.","journal-title":"J Clin Invest"},{"issue":"6","key":"8_CR161","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1172\/JCI32482","volume":"117","author":"SE Quaggin","year":"2007","unstructured":"Quaggin SE. Sizing up sialic acid in glomerular disease. J Clin Invest 2007; 117(6):1480\u20131483.","journal-title":"J Clin Invest"},{"issue":"12","key":"8_CR162","doi-asserted-by":"crossref","first-page":"7756","DOI":"10.1074\/jbc.M509668200","volume":"281","author":"S Ueno","year":"2006","unstructured":"Ueno S, Saito S, Wada T et al. Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility. J Biol Chem 2006;281(12):7756\u20137764.","journal-title":"J Biol Chem"},{"issue":"3","key":"8_CR163","first-page":"1009","volume":"149","author":"H Holth\u00f6fer","year":"1996","unstructured":"Holth\u00f6fer H, Reivinen J, Solin ML et al. Decrease of glomerular disialogangliosides in puromycin nephrosis of the rat. Am J Pathol 1996; 149(3): 1009\u20131015.","journal-title":"Am J Pathol"},{"issue":"12","key":"8_CR164","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1093\/ndt\/gfp427","volume":"24","author":"S Trivedi","year":"2009","unstructured":"Trivedi S, Zeier M, Reiser J. Role of podocytes in lupus nephritis. Nephrol Dial Transplant 2009; 24(12):3607\u20133612.","journal-title":"Nephrol Dial Transplant"},{"key":"8_CR165","doi-asserted-by":"crossref","unstructured":"Dong L, Hu S, Chen F et al. Increased expression of ganglioside GM1 inperipheral CD4+ T-cells correlates soluble form of CD30 in Systemic Lupus Erythematosus patients. J Biomed Biotechnol 2010:569053.","DOI":"10.1155\/2010\/569053"},{"key":"8_CR166","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-1-4684-1200-0_30","volume":"174","author":"P Lacetti","year":"1984","unstructured":"Lacetti P, Tombaccini D, Aloj S et al. Gangliosides, the thyrotropin receptor and autoimmune thyroid disease. Adv Exp Med Biol 1984; 174:355\u2013367.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"8_CR167","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1099-0895(199709)13:3<163::AID-DMR189>3.0.CO;2-Z","volume":"13","author":"R Misasi","year":"1997","unstructured":"Misasi R, Dionisi S, Farilla L et al. Gangliosides and autoimmune diabetes. Diabetes Metab Rev 1997; 13(3):163\u2013179.","journal-title":"Diabetes Metab Rev"},{"issue":"5","key":"8_CR168","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/glycob\/cwn017","volume":"18","author":"K Miyamoto","year":"2008","unstructured":"Miyamoto K, Takada K, Furukawa K et al. Roles of complex gangliosides in the development of experimental autoimmune encephalomyelitis. Glycobiology 2008; 18(5):408\u2013413.","journal-title":"Glycobiology"},{"issue":"2","key":"8_CR169","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0304-3940(76)90033-1","volume":"2","author":"Y Nagai","year":"1976","unstructured":"Nagai Y, Momoi T, Saito M et al. Ganglioside syndrome, a new autoimmune neurologic disorder, experimentally induced with brain gangliosides. Neurosci Lett 1976; 2(2):107\u2013111.","journal-title":"Neurosci Lett"},{"issue":"5","key":"8_CR170","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ana.410300508","volume":"30","author":"D Ponzin","year":"1991","unstructured":"Ponzin D, Menegus AM, Kirschner G et al. Effects of gangliosides on the expression of autoimmune demyelination in the peripheral nervous system. Ann Neurol 1991; 30(5):678\u2013685.","journal-title":"Ann Neurol"},{"key":"8_CR171","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1136\/jnnp.57.Suppl.26","volume":"57","author":"AJ Steck","year":"1994","unstructured":"Steck AJ, Kappos L. Gangliosides and autoimmune neuropathies: classification and clinical aspects of autoimmune neuropathies. J Neurol Neurosurg Psychiatry 1994; 57 Suppl:26\u201328.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl 1","key":"8_CR172","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1471-4159.2007.04718.x","volume":"103","author":"HJ Willison","year":"2007","unstructured":"Willison HJ. Gangliosides as targets for autoimmune injury to the nervous system. J Neurochem 2007; 103Suppl 1:143\u2013149.","journal-title":"J Neurochem"},{"issue":"1","key":"8_CR173","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2353\/ajpath.2007.061116","volume":"171","author":"SJ Harvey","year":"2007","unstructured":"Harvey SJ, Jarad G, Cunningham J et al. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am J Pathol 2007; 171(1):139\u2013152.","journal-title":"Am J Pathol"},{"issue":"3","key":"8_CR174","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ki.2008.159","volume":"74","author":"S Chen","year":"2008","unstructured":"Chen S, Wassenhove-McCarthy DJ, Yamaguchi Y et al. Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria. Kidney Int 2008; 74(3):289\u2013299.","journal-title":"Kidney Int"},{"issue":"25","key":"8_CR175","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM198106183042502","volume":"304","author":"B Rodriguez-Iturbe","year":"1981","unstructured":"Rodriguez-Iturbe B, Katiyar VN, Coello J. Neuraminidase activity and free sialic acid levels in the serum of patients with acute poststreptococcal glomerulonephritis. N Engl J Med 1981; 304(25):1506\u20131510.","journal-title":"N Engl J Med"},{"issue":"1","key":"8_CR176","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1042\/cs0690057","volume":"69","author":"L Laitinen","year":"1985","unstructured":"Laitinen L, Miettinen A, Tikkanen I et al. Glomerular sialic acid in Heymann nephritis and diacetylbenzidine induced nephropathy in rats. Clin Sci (Lond) 1985; 69(1):57\u201362.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"8_CR177","first-page":"21","volume":"21","author":"J Mosquera","year":"1984","unstructured":"Mosquera J, Rodriguez-Iturbe B. Extracellular neuraminidase production of streptococci associated with acute nephritis. Clin Nephrol 1984; 21(1):21\u201328.","journal-title":"Clin Nephrol"},{"issue":"3","key":"8_CR178","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1172\/JCI116299","volume":"91","author":"IZ Zador","year":"1993","unstructured":"Zador IZ, Deshmukh GD, Kunkel R et al. A role for glycosphingolipid accumulation in the renal hypertrophy of streptozotocin-induced diabetes mellitus. J Clin Invest 1993; 91(3):797\u2013803.","journal-title":"J Clin Invest"},{"issue":"7","key":"8_CR179","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1194\/jlr.M700090-JLR200","volume":"48","author":"N Morral","year":"2007","unstructured":"Morral N, Edenberg HJ, Witting SR et al. Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver. J Lipid Res 2007; 48(7):1499\u20131510.","journal-title":"J Lipid Res"},{"issue":"5","key":"8_CR180","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2337\/db06-1619","volume":"56","author":"JM Aerts","year":"2007","unstructured":"Aerts JM, Ottenhoff R, Powlson AS et al. Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity. Diabetes 2007; 56(5):1341\u20131349.","journal-title":"Diabetes"},{"issue":"5","key":"8_CR181","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/db06-0719","volume":"56","author":"H Zhao","year":"2007","unstructured":"Zhao H, Przybylska M, Wu IH et al. Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes. Diabetes 2007; 56(5):1210\u20131218.","journal-title":"Diabetes"},{"issue":"6","key":"8_CR182","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1073\/pnas.0635898100","volume":"100","author":"T Yamashita","year":"2003","unstructured":"Yamashita T, Hashiramoto A, Haluzik M et al. Enhanced insulin sensitivity in mice lacking ganglioside GM3. Proc Natl Acad Sci USA 2003; 100(6):3445\u20133449.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR183","doi-asserted-by":"crossref","unstructured":"Cheng ZJ, Singh RD, Wang TK et al. Stimulation of GLUT4 (glucose transporter isoform 4) storage vesicle formation by sphingolipid depletion. Biochem J 427(1):143\u2013150.","DOI":"10.1042\/BJ20091529"},{"issue":"1","key":"8_CR184","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0304-4165(84)90222-8","volume":"801","author":"L Cohen-Forterre","year":"1984","unstructured":"Cohen-Forterre L, Mozere G, Andre J et al. Studies on kidney sialidase in normal and diabetic rats. Biochim Biophys Acta 1984; 801(1):138\u2013145.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"8_CR185","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/0885-4505(91)90089-4","volume":"46","author":"A C\u00e1rdenas","year":"1991","unstructured":"C\u00e1rdenas A, Schadeck C, Bernard A et al. Depletion of sialic acid without changes in sialidase activity in glomeruli of uninephrectomized diabetic rats. Biochem Med Metab Biol 1991; 46(3):416\u2013421.","journal-title":"Biochem Med Metab Biol"},{"issue":"3","key":"8_CR186","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1042\/bj2390705","volume":"239","author":"WH Baricos","year":"1986","unstructured":"Baricos WH, Cortez-Schwartz S, Shah SV. Renal neuraminidase. Characterization in normal rat kidney and measurement in experimentally induced nephrotic syndrome. Biochem J 1986; 239(3):705\u2013710.","journal-title":"Biochem J"},{"key":"8_CR187","doi-asserted-by":"crossref","unstructured":"Boini KM, Zhang C, Xia M et al. Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet. J Pharmacol Exp Ther 334(3):839\u2013846.","DOI":"10.1124\/jpet.110.168815"},{"key":"8_CR188","unstructured":"Deevska GM, Nikolova-Karakashian MN. The twists and turns of sphingolipid pathway in glucose regulation. Biochimie."},{"key":"8_CR189","doi-asserted-by":"crossref","unstructured":"Wennekes T, Meijer AJ, Groen AK et al. Dual-action lipophilic iminosugar improves glycemic control in obese rodents by reduction of visceral glycosphingolipids and buffering of carbohydrate assimilation. J Med Chem 53(2):689\u2013698.","DOI":"10.1021\/jm901281m"},{"key":"8_CR190","doi-asserted-by":"crossref","unstructured":"Yew NS, Zhao H, Hong EG et al. Increased hepatic insulin action in diet-induced obese mice following inhibition of glucosylceramide synthase. PLoS One 5(6):e11239.","DOI":"10.1371\/journal.pone.0011239"}],"container-title":["Advances in Experimental Medicine and Biology","Sphingolipids and Metabolic Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-0650-1_8.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T01:23:49Z","timestamp":1638581029000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4614-0650-1_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9781461406495","9781461406501"],"references-count":190,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-0650-1_8","relation":{},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}